Detalhe da pesquisa
1.
Tolerability of Olaparib Combined with Abiraterone in Patients with Metastatic Castration-resistant Prostate Cancer: Further Results from the Phase 3 PROpel Trial.
Eur Urol Oncol
; 2024 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38582650